What is NDC 70710-1348?

70710-1348 is the product NDC for Venlafaxine, Venlafaxine hydrochloride 37.5 mg/1 tablet, extended release, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Venlafaxine?

118 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Venlafaxine NDC 70710-1348 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1348Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1348Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70710-1348-1	7071013480170710134801	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1348-1)Marketed from Sep 1, 2022
70710-1348-3	7071013480370710134803	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1348-3)Marketed from Sep 1, 2022
70710-1348-9	7071013480970710134809	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1348-9)Marketed from Sep 1, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Venlafaxine
Generic name (nonproprietary): venlafaxine
Active ingredients: Venlafaxine hydrochloride — 37.5 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215622
Marketing start: Sep 1, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 70710-1348_479c565e-3c2f-42a1-8a19-b7a210e5f28dSPL ID 479c565e-3c2f-42a1-8a19-b7a210e5f28dSPL set ID db1d16b3-d1a2-4f41-adff-a87c17689aa0RxCUI 808744, 808748, 808751, 808753UNII 7D7RX5A8MO
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710134801 followed by a unit qualifier and the quantity

Package 70710-1348-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 1, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Venlafaxine extended-release tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1.1 ) Social Anxiety Disorder (SAD) ( 1.2 ) 1.1 Major Depressive Disorder Venlafaxine extended-release tablets are indicated for the treatment of major depressive disorder (MDD). Efficacy of venlafaxine in MDD was shown in both short-term trials and a longer-term trial in MDD [see Clinical Studies ( 14.1 )]. A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previou…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70710-1348

What is NDC 70710-1348?: 70710-1348 is the product NDC for Venlafaxine, Venlafaxine hydrochloride 37.5 mg/1 tablet, extended release, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Venlafaxine.
What is the active ingredient?: Venlafaxine hydrochloride.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Venlafaxine?: 118 other product NDCs are listed under this name. See all Venlafaxine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Venlafaxine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Venlafaxine	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4779	70518-4779-00
venlafaxinevenlafaxine hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	Coupler LLC	67046-0560	67046-0560-03
venlafaxine	Venlafaxine hydrochloride 50 mg/1	TabletOral	Coupler LLC	67046-1681	67046-1681-03
venlafaxine	Venlafaxine hydrochloride 75 mg/1	TabletOral	Coupler LLC	67046-2020	67046-2020-03
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4566	70518-4566-00
Venlafaxine	Venlafaxine hydrochloride 150 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4500	70518-4500-00
venlafaxine	Venlafaxine hydrochloride 75 mg/1	TabletOral	REMEDYREPACK INC.	70518-4168	70518-4168-00
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3820	70518-3820-00
venlafaxinevenlafaxine hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	Northwind Health Company, LLC	51655-323	51655-0323-52
Venlafaxine	Venlafaxine hydrochloride 37.5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-728	60760-0728-60

All 119 Venlafaxine NDCs

Other NDCs under ANDA 215622

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215622
Product	Strength	Form · route	Labeler	Product NDC
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4566
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-1349
Venlafaxine	Venlafaxine hydrochloride 150 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-1350
Venlafaxine	Venlafaxine hydrochloride 225 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals USA Inc.	70710-1352
Venlafaxine	Venlafaxine hydrochloride 37.5 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1649
Venlafaxine	Venlafaxine hydrochloride 75 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1650
Venlafaxine	Venlafaxine hydrochloride 150 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1651
Venlafaxine	Venlafaxine hydrochloride 225 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1652